Vaccinations are one of the most effective public health interventions, but what evidence is there of their economic and social value? Is there really a return on investment and what are the interlinks with health, work and prosperity? In this episode, Matthew Taylor put these questions, and more, to Lotte Steuten, deputy chief executive of the Office of Health Economics and Chris Thomas, head of the Health and Prosperity Commission at the IPPR, whose organisations have delved into the detail of these issues.
Tune in for insights on the ROI to the economy and health service, implications on elective recovery, the impact of in-work sickness and lessons from the COVID-19 pandemic.
Advisory note: A number of licenses have now been granted for vaccinations and immunisations against respiratory syncytial virus (RSV) in the UK.
","author_name":"The NHS Alliance"}